FI
ALXN

Fosun International’s Alexion Pharmaceuticals ALXN Stock Holding History

Fosun International’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,000
Closed -$757K – 241
2019
Q4 		$757K Sell
7,000
-25,900
-79% -$2.77M 0.06% 132
2019
Q3 		$3.22M Buy
32,900
+28,410
+633% +$3.2M 0.36% 42
2019
Q2 		$566K Buy
+4,490
New +$579K 0.04% 213
2019
Q1 		– Sell
-33,224
Closed -$3.23M – 336
2018
Q4 		$3.23M Sell
33,224
-21,000
-39% -$2.48M 0.19% 60
2018
Q3 		$7.52M Buy
54,224
+2,819
+5% +$354K 0.36% 33
2018
Q2 		$6.38M Buy
51,405
+18,181
+55% +$2.12M 0.33% 40
2018
Q1 		$3.7M Buy
+33,224
New +$3.97M 0.23% 40

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return